The track by which API manufacturing processes are prepared for commercial use is comparable to overlapping integrative process evaluations at commercial scale. This ensures the process is ...

Nimesh Khadka: Hot melt extrusion is widely used to improve drug solubility, bioavailability, and stability, but the process ...

While trade groups hail the executive order as a national health security opportunity, analysts warn that production costs ...

AbbVie (ABBV) announced a $195M investment in its North Chicago, Illinois manufacturing plant to expand domestic active pharmaceutical ingredient production in the U.S.

The market size for the contract manufacturing of active pharmaceutical ingredient (API) in peptide therapeutics is anticipated to experience significant expansion in the coming years.

AbbVie is investing $195m to strengthen domestic active pharmaceutical ingredient (API) production within the US, with the expansion of its manufacturing plant in North Chicago, Illinois.

Further, Indiana Chem-Port failed to show that its manufacturing process could consistently reproduce API to necessary quality standards.

C2 Pharma already has a long-term supply agreement and partnership with Indian API maker Laurus Labs. Last fall, the two validated the manufacturing process for two APIs, digoxin and digoxin ...